文献速递肝胆胰外科

背景肝硬化对肝细胞癌肝切除术后结局的影响

Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma.
PubMed 文献 · JAMA Surg · 2017-03-15

该回顾性匹配研究比较了64例正常肝脏与64例肝硬化患者肝细胞癌根治性肝切除术后的复发模式与生存。

要点

  • 肝硬化组远处孤立复发更常见,正常肝脏组切缘附近多发或肝外复发更常见。

核心结论

  • 肝硬化组预后较差可能归因于肝硬化患者具有更高的肝癌发生潜能。
  • 两组的年复发率提示,新发复发可能在肝切除术后早期至晚期持续发生。

研究设计与样本

  • 回顾性收集1995年1月1日至2014年12月31日在虎之门医院和约翰霍普金斯医院接受肝细胞癌根治性肝切除术的799例患者数据。
  • 424例符合纳入标准,其中正常肝脏73例、肝硬化351例;64例组织学证实正常肝脏实质的患者与等量确诊肝硬化患者匹配,比较术后结局。
  • 匹配后研究人群共128例,平均(标准差)年龄64.0(12.7)岁,男性93例、女性35例。

临床怎么用

  • 对肝硬化肝细胞癌患者行肝切除术后应加强复发监测,警惕新发复发从早期持续至晚期。
  • 复发模式差异提示肝硬化患者需关注远处孤立复发,正常肝脏患者需关注切缘附近多发或肝外复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Background hepatocarcinogenesis is considered a major cause of postoperative recurrence of de novo hepatocellular carcinoma (HCC) in patients with liver cirrhosis (LC). The degree of underlying liver injury has reportedly correlated with surgical outcomes of HCC. However, the pattern and annual rate of recurrence of postoperative de novo HCC are still unclear. OBJECTIVE: To clarify the pattern and rate of recurrence of de novo HCC in patients with LC. DESIGN, SETTING, AND PARTICIPANTS: Data from 799 patients who underwent curative hepatectomy for HCC at Toranomon Hospital and The Johns Hopkins Hospital between January 1, 1995, and December 31, 2014, were retrospectively collected and analyzed. Of the patients who underwent curative hepatectomy for HCC, 424 met inclusion criteria: 73 with normal liver (NL) and 351 with LC. Sixty-four patients who had histologically proven NL parenchyma were matched with an equal number of patients who had established LC, and postoperative outcomes were compared. INTERVENTIONS: Hepatectomy in patients with HCC. MAIN OUTCOMES AND MEASURES: Patterns of recurrence of HCC and chronological changes in recurrence rates. RESULTS: Among 128 matched patients in the study (mean [SD] age, 64.0 [12.7] years; 93 men and 35 women) 1-, 3-, and 5-year cumulative recurrence was 17.2%, 23.0%, and 37.5%, respectively, in the NL group vs 25.0%, 55.5%, and 72.1%, respectively, in the LC group (P = .001). The 3- and 5-year disease-specific survival was 85.7% and 75.4%, respectively, in the NL group vs 74.9% and 59.1%, respectively, in the LC group (P = .04). The median annual incidence of postoperative recurrence of HCC within 5 years after surgery was lower in the NL group (5.9%) compared with the LC group (12.7%) (P = .003). Assessment of recurrence patterns revealed that multiple recurrences near the resection margin or at extrahepatic sites were more frequent in the NL group (9 [50.0%] vs 6 [15.4%]; P = .01), whereas solitary recurrence at a distant site was more common in the LC group (21 [53.8%] vs 1 [5.6%]; P < .001). CONCLUSIONS AND RELEVANCE: Comparison of the patterns and annual incidence of recurrence of HCC demonstrated that the poorer prognosis in the LC group was likely owing to a higher hepatocarcinogenic potential among patients with cirrhosis. Annual recurrence rates in the 2 groups indicate that de novo recurrence may continuously occur from the early postoperative period until the late period after resection of HCC.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Sasaki K, Shindoh J, Margonis GA, et al. Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma. JAMA Surg. 2017. PMID: 28052155. doi:10.1001/jamasurg.2016.5059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。